Back
Xerox Holdings Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
45
XRX
Xerox Holdings
Last Price:
10.19
Seasonality Move:
4.03%
Sell
32
BMRN
Biomarin Pharmaceutical
Last Price:
68.71
Seasonality Move:
11.99%
Sell
45
Xerox Holdings (XRX)
is a Sell
Is Xerox Holdings a Buy, Sell or Hold?
- The current Xerox Holdings [XRX] share price is $10.38. The Score for XRX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- XRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $68.96. The Score for BMRN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XRX Stock Price Chart
What is Xerox Holdings's stock price today?
-
The Xerox Holdings share price today is $10.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XRX is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $68.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
XRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 48.94 | Sell |
| Chaikin Money Flow: | -550272 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.12 - 10.62) | Buy |
| Bollinger Bands (100): | (10.08 - 13.12) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.13 | Sell |
| Relative Strength Index (14 RSI): | 29.24 | Sell |
| Chaikin Money Flow: | 270547 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.81 - 83.61) | Sell |
| Bollinger Bands (100): | (75.16 - 88.58) | Sell |
XRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.38 | Sell |
| 20-day SMA: | 10.34 | Buy |
| 50-day SMA: | 10.4 | Sell |
| 200-day SMA: | 14.27 | Sell |
| 8-day EMA: | 10.37 | Buy |
| 20-day EMA: | 10.39 | Sell |
| 50-day EMA: | 10.71 | Sell |
| 200-day EMA: | 13.02 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.69 | Sell |
| 20-day SMA: | 72.88 | Sell |
| 50-day SMA: | 82.11 | Sell |
| 200-day SMA: | 85.37 | Sell |
| 8-day EMA: | 69.73 | Sell |
| 20-day EMA: | 73.23 | Sell |
| 50-day EMA: | 78.72 | Sell |
| 200-day EMA: | 84.16 | Sell |
Xerox Holdings Earnings Growth & XRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and an increase next year of $0.09 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Xerox Holdings Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||